Zhou HH - Search Results

1

Considerable impacts of AGXT2 V140I polymorphism on chronic heart failure in the Chinese population.

Hu XL, Zhou JP, Kuang DB, Qi H, Peng LM, Yang TL, Li X, Zhang W, Zhou HH, Chen XP. Hu XL, et al. Among authors: zhou jp, zhou hh. Atherosclerosis. 2016 Aug;251:255-262. doi: 10.1016/j.atherosclerosis.2016.07.006. Epub 2016 Jul 7. Atherosclerosis. 2016. PMID: 27423328

2

Pharmacokinetics of sertraline in relation to genetic polymorphism of CYP2C19.

Wang JH, Liu ZQ, Wang W, Chen XP, Shu Y, He N, Zhou HH. Wang JH, et al. Among authors: zhou hh. Clin Pharmacol Ther. 2001 Jul;70(1):42-7. doi: 10.1067/mcp.2001.116513. Clin Pharmacol Ther. 2001. PMID: 11452243

3

Effect of the CYP2C19 oxidation polymorphism on fluoxetine metabolism in Chinese healthy subjects.

Liu ZQ, Cheng ZN, Huang SL, Chen XP, Ou-Yang DS, Jiang CH, Zhou HH. Liu ZQ, et al. Among authors: zhou hh. Br J Clin Pharmacol. 2001 Jul;52(1):96-9. doi: 10.1046/j.0306-5251.2001.01402.x. Br J Clin Pharmacol. 2001. PMID: 11453896 Free PMC article.

4

Plasma caffeine metabolite ratio (17X/137X) in vivo associated with G-2964A and C734A polymorphisms of human CYP1A2.

Han XM, Ou-Yang DS, Lu PX, Jiang CH, Shu Y, Chen XP, Tan ZR, Zhou HH. Han XM, et al. Among authors: zhou hh. Pharmacogenetics. 2001 Jul;11(5):429-35. doi: 10.1097/00008571-200107000-00006. Pharmacogenetics. 2001. PMID: 11470995

5

G-2964A and C734A genetic polymorphisms of CYP1A2 in Chinese population.

Han XM, Chen XP, Wu QN, Jiang CH, Zhou HH. Han XM, et al. Among authors: zhou hh. Acta Pharmacol Sin. 2000 Nov;21(11):1031-4. Acta Pharmacol Sin. 2000. PMID: 11501059 Free article.

6

Assessment of cytochrome P450 activity by a five-drug cocktail approach.

Zhu B, Ou-Yang DS, Chen XP, Huang SL, Tan ZR, He N, Zhou HH. Zhu B, et al. Among authors: zhou hh. Clin Pharmacol Ther. 2001 Nov;70(5):455-61. doi: 10.1067/mcp.2001.119813. Clin Pharmacol Ther. 2001. PMID: 11719732

7

The role of CYP2C19 in amitriptyline N-demethylation in Chinese subjects.

Jiang ZP, Shu Y, Chen XP, Huang SL, Zhu RH, Wang W, He N, Zhou HH. Jiang ZP, et al. Among authors: zhou hh. Eur J Clin Pharmacol. 2002 May;58(2):109-13. doi: 10.1007/s00228-002-0445-6. Epub 2002 Apr 11. Eur J Clin Pharmacol. 2002. PMID: 12012142 Clinical Trial.

8

Genotype of CYP3AP1 associated with CYP3A activity in Chinese Han population.

Zhu B, Chen GL, Chen XP, He N, Liu ZQ, Jiang CH, Wang D, Zhou HH. Zhu B, et al. Among authors: zhou hh. Acta Pharmacol Sin. 2002 Jun;23(6):567-72. Acta Pharmacol Sin. 2002. PMID: 12060534 Free article.

9

Inducibility of CYP1A2 by omeprazole in vivo related to the genetic polymorphism of CYP1A2.

Han XM, Ouyang DS, Chen XP, Shu Y, Jiang CH, Tan ZR, Zhou HH. Han XM, et al. Among authors: zhou hh. Br J Clin Pharmacol. 2002 Nov;54(5):540-3. doi: 10.1046/j.1365-2125.2002.01686.x. Br J Clin Pharmacol. 2002. PMID: 12445035 Free PMC article. Clinical Trial.

10

Phenotype distribution and gender-related differences of CYP2E1 activity in a Chinese population.

Chen XP, Han XM, Jiang CH, Huang SL, Liu ZQ, Zhu B, Zhou G, Zhou HH. Chen XP, et al. Among authors: zhou g, zhou hh. Xenobiotica. 2002 Nov;32(11):1053-62. doi: 10.1080/00498250210163270. Xenobiotica. 2002. PMID: 12487734

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

725 results

Search Page

Filters